<!DOCTYPE html>
<html lang="en-us">

<head>

  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="generator" content="Source Themes Academic 4.5.0">

  

  
  
  
  
  
    
    
    
  
  

  <meta name="author" content="Eric S. Kawaguchi">

  
  
  
    
  
  <meta name="description" content="Glioblastoma is the most common primary malignant brain tumor in adults and is associated with poor survival. The Ivy Foundation Early Phase Clinical Trials Consortium conducted a randomized, multi-institution clinical trial to evaluate immune responses and survival following neoadjuvant and/or adjuvant therapy with pembrolizumab in 35 patients with recurrent, surgically resectable glioblastoma.">

  
  <link rel="alternate" hreflang="en-us" href="/project/pubs-nature-copy/">

  


  
  
  
  <meta name="theme-color" content="#2962ff">
  

  
  
  
  
    
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/academicons/1.8.6/css/academicons.min.css" integrity="sha256-uFVgMKfistnJAfoCUQigIl+JfUaP47GrRKjf6CTPVmw=" crossorigin="anonymous">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.11.2/css/all.min.css" integrity="sha256-+N4/V/SbAFiW1MPBCXnfnP9QSN3+Keu+NlB+0ev/YKQ=" crossorigin="anonymous">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/fancybox/3.5.7/jquery.fancybox.min.css" integrity="sha256-Vzbj7sDDS/woiFS3uNKo8eIuni59rjyNGtXfstRzStA=" crossorigin="anonymous">

    
    
    
      
    
    
      
      
        
          <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.15.10/styles/github.min.css" crossorigin="anonymous" title="hl-light">
          <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.15.10/styles/dracula.min.css" crossorigin="anonymous" title="hl-dark" disabled>
        
      
    

    

    

  

  
  
  
  <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Montserrat:400,700%7CRoboto:400,400italic,700%7CRoboto+Mono&display=swap">
  

  
  
  
  
  <link rel="stylesheet" href="/css/academic.css">

  




  


  

  <link rel="manifest" href="/index.webmanifest">
  <link rel="icon" type="image/png" href="/img/icon-32.png">
  <link rel="apple-touch-icon" type="image/png" href="/img/icon-192.png">

  <link rel="canonical" href="/project/pubs-nature-copy/">

  
  
  
  
    
    
  
  
  <meta property="twitter:card" content="summary">
  
  <meta property="og:site_name" content="ESK">
  <meta property="og:url" content="/project/pubs-nature-copy/">
  <meta property="og:title" content="Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma | ESK">
  <meta property="og:description" content="Glioblastoma is the most common primary malignant brain tumor in adults and is associated with poor survival. The Ivy Foundation Early Phase Clinical Trials Consortium conducted a randomized, multi-institution clinical trial to evaluate immune responses and survival following neoadjuvant and/or adjuvant therapy with pembrolizumab in 35 patients with recurrent, surgically resectable glioblastoma."><meta property="og:image" content="/img/icon-192.png">
  <meta property="twitter:image" content="/img/icon-192.png"><meta property="og:locale" content="en-us">
  
    
      <meta property="article:published_time" content="2017-01-01T00:00:00&#43;00:00">
    
    <meta property="article:modified_time" content="2019-02-11T00:00:00&#43;00:00">
  

  


    











<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "Article",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "/project/pubs-nature-copy/"
  },
  "headline": "Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma",
  
  "datePublished": "2017-01-01T00:00:00Z",
  "dateModified": "2019-02-11T00:00:00Z",
  
  "author": {
    "@type": "Person",
    "name": "Eric S. Kawaguchi"
  },
  
  "publisher": {
    "@type": "Organization",
    "name": "ESK",
    "logo": {
      "@type": "ImageObject",
      "url": "/img/icon-512.png"
    }
  },
  "description": "Glioblastoma is the most common primary malignant brain tumor in adults and is associated with poor survival. The Ivy Foundation Early Phase Clinical Trials Consortium conducted a randomized, multi-institution clinical trial to evaluate immune responses and survival following neoadjuvant and/or adjuvant therapy with pembrolizumab in 35 patients with recurrent, surgically resectable glioblastoma."
}
</script>

  

  


  


  





  <title>Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma | ESK</title>

</head>

<body id="top" data-spy="scroll" data-offset="70" data-target="#TableOfContents" >

  <aside class="search-results" id="search">
  <div class="container">
    <section class="search-header">

      <div class="row no-gutters justify-content-between mb-3">
        <div class="col-6">
          <h1>Search</h1>
        </div>
        <div class="col-6 col-search-close">
          <a class="js-search" href="#"><i class="fas fa-times-circle text-muted" aria-hidden="true"></i></a>
        </div>
      </div>

      <div id="search-box">
        
        
        
      </div>

    </section>
    <section class="section-search-results">

      <div id="search-hits">
        
      </div>

    </section>
  </div>
</aside>


  
<nav class="navbar navbar-light fixed-top navbar-expand-lg py-0 compensate-for-scrollbar" id="navbar-main">
  <div class="container">

    
      <a class="navbar-brand" href="/">ESK</a>
      
      <button type="button" class="navbar-toggler" data-toggle="collapse"
              data-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
        <span><i class="fas fa-bars"></i></span>
      </button>
      

    
    <div class="collapse navbar-collapse" id="navbar">

      
      
      <ul class="navbar-nav ml-auto">
        

        

        
        
        
          
        

        
        
        
        
        
        
          
          
          
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/#research"><span>Research</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        
          
          
          
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/#teaching"><span>Teaching</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        
          
          
          
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/#posts"><span>Recent Posts</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        
          
          
          
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/#contact"><span>Contact</span></a>
        </li>

        
        

      

        

        

        

        

      </ul>

    </div>
  </div>
</nav>


  <article class="article article-project">

  












  

  
  
  
<div class="article-container pt-3">
  <h1>Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma</h1>

  

  
    


<div class="article-metadata">

  
  

  
  <span class="article-date">
    
    
      
    
    Feb 11, 2019
  </span>
  

  

  

  
  
  

  
  

</div>

    











  



<div class="btn-links mb-3">
  
  <a class="btn btn-outline-primary my-1" href="https://www.nature.com/articles/s41591-018-0337-7" target="_blank" rel="noopener">Go to Project Site</a>
  
  








  
    
  



<a class="btn btn-outline-primary my-1 mr-1" href="https://www.nature.com/articles/s41591-018-0337-7" target="_blank" rel="noopener">
  PDF
</a>



<button type="button" class="btn btn-outline-primary my-1 mr-1 js-cite-modal"
        data-filename="/project/pubs-nature-copy/cite.bib">
  Cite
</button>













<a class="btn btn-outline-primary my-1 mr-1" href="https://doi.org/10.1038/s41591-018-0337-7" target="_blank" rel="noopener">
  DOI
</a>



</div>


  
</div>



  <div class="article-container">

    <div class="article-style">
      
    </div>

    





<div class="article-tags">
  
  <a class="badge badge-light" href="/tags/pubs/">pubs</a>
  
</div>



<div class="share-box" aria-hidden="true">
  <ul class="share">
    
      
      
      
        
      
      
      
      <li>
        <a href="https://twitter.com/intent/tweet?url=/project/pubs-nature-copy/&amp;text=Neoadjuvant%20anti-PD-1%20immunotherapy%20promotes%20a%20survival%20benefit%20with%20intratumoral%20and%20systemic%20immune%20responses%20in%20recurrent%20glioblastoma" target="_blank" rel="noopener" class="share-btn-twitter">
          <i class="fab fa-twitter"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://www.facebook.com/sharer.php?u=/project/pubs-nature-copy/&amp;t=Neoadjuvant%20anti-PD-1%20immunotherapy%20promotes%20a%20survival%20benefit%20with%20intratumoral%20and%20systemic%20immune%20responses%20in%20recurrent%20glioblastoma" target="_blank" rel="noopener" class="share-btn-facebook">
          <i class="fab fa-facebook"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="mailto:?subject=Neoadjuvant%20anti-PD-1%20immunotherapy%20promotes%20a%20survival%20benefit%20with%20intratumoral%20and%20systemic%20immune%20responses%20in%20recurrent%20glioblastoma&amp;body=/project/pubs-nature-copy/" target="_blank" rel="noopener" class="share-btn-email">
          <i class="fas fa-envelope"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://www.linkedin.com/shareArticle?url=/project/pubs-nature-copy/&amp;title=Neoadjuvant%20anti-PD-1%20immunotherapy%20promotes%20a%20survival%20benefit%20with%20intratumoral%20and%20systemic%20immune%20responses%20in%20recurrent%20glioblastoma" target="_blank" rel="noopener" class="share-btn-linkedin">
          <i class="fab fa-linkedin-in"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://web.whatsapp.com/send?text=Neoadjuvant%20anti-PD-1%20immunotherapy%20promotes%20a%20survival%20benefit%20with%20intratumoral%20and%20systemic%20immune%20responses%20in%20recurrent%20glioblastoma%20/project/pubs-nature-copy/" target="_blank" rel="noopener" class="share-btn-whatsapp">
          <i class="fab fa-whatsapp"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://service.weibo.com/share/share.php?url=/project/pubs-nature-copy/&amp;title=Neoadjuvant%20anti-PD-1%20immunotherapy%20promotes%20a%20survival%20benefit%20with%20intratumoral%20and%20systemic%20immune%20responses%20in%20recurrent%20glioblastoma" target="_blank" rel="noopener" class="share-btn-weibo">
          <i class="fab fa-weibo"></i>
        </a>
      </li>
    
  </ul>
</div>












  






  
  
  
    
  
  
  <div class="media author-card content-widget-hr">
    
      
      <img class="portrait mr-3" src="/authors/admin/avatar_hue776a334b902d7828bf5c7a8aa11ccb3_990352_250x250_fill_q90_lanczos_center.jpg" alt="Avatar">
    

    <div class="media-body">
      <h5 class="card-title"><a href="/">Eric S. Kawaguchi</a></h5>
      <h6 class="card-subtitle">Postdoctoral Research Associate</h6>
      
      <ul class="network-icon" aria-hidden="true">
  
    
    
    
      
    
    
    
    
    
      
    
    <li>
      <a href="/#contact" >
        <i class="fas fa-envelope"></i>
      </a>
    </li>
  
    
    
    
      
    
    
    
    
    
      
    
    <li>
      <a href="https://github.com/erickawaguchi" target="_blank" rel="noopener">
        <i class="fab fa-github"></i>
      </a>
    </li>
  
    
    
    
      
    
    
    
    
    
      
    
    <li>
      <a href="https://www.linkedin.com/in/erickawaguchi/" target="_blank" rel="noopener">
        <i class="fab fa-linkedin"></i>
      </a>
    </li>
  
    
    
    
    
    
    
    
      
    
    <li>
      <a href="https://orcid.org/0000-0003-2014-5023" target="_blank" rel="noopener">
        <i class="ai ai-orcid"></i>
      </a>
    </li>
  
</ul>

    </div>
  </div>









  
  
  <div class="article-widget content-widget-hr">
    <h3>Related</h3>
    <ul>
      
      <li><a href="/project/pubs-nature/">Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma</a></li>
      
    </ul>
  </div>
  



    <div class="project-related-pages content-widget-hr">
      
      

      
      
      

      
      
      

      
      
      
    </div>
  </div>
</article>

      

    
    
    
    <script src="/js/mathjax-config.js"></script>
    

    
    
    
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.4.1/jquery.min.js" integrity="sha256-CSXorXvZcTkaix6Yvo6HppcZGetbYMGWSFlBw8HfCJo=" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.imagesloaded/4.1.4/imagesloaded.pkgd.min.js" integrity="sha256-lqvxZrPLtfffUl2G/e7szqSvPBILGbwmsGE1MKlOi0Q=" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.isotope/3.0.6/isotope.pkgd.min.js" integrity="sha256-CBrpuqrMhXwcLLUd5tvQ4euBHCdh7wGlDfNz8vbu/iI=" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/fancybox/3.5.7/jquery.fancybox.min.js" integrity="sha256-yt2kYMy0w8AbtF89WXb2P1rfjcP/HTHLT7097U8Y5b8=" crossorigin="anonymous"></script>

      

      
        
        <script src="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.15.10/highlight.min.js" integrity="sha256-1zu+3BnLYV9LdiY85uXMzii3bdrkelyp37e0ZyTAQh0=" crossorigin="anonymous"></script>
        
        <script src="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.15.10/languages/r.min.js"></script>
        
      

      
      
      <script src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-chtml.js" integrity="" crossorigin="anonymous" async></script>
      
    

    
    

    
    
    <script>hljs.initHighlightingOnLoad();</script>
    

    

    
    

    

    
    

    
    

    
    

    
    
    
    
    
    
    
    
    
    
    
    
    <script src="/js/academic.min.368ad8701ddf69c34950016f6435139b.js"></script>

    






  
  
  <div class="container">
    <footer class="site-footer">
  
  <p class="powered-by">
    
      <a href="/privacy/">Privacy Policy</a>
    
    
       &middot; 
      <a href="/terms/">Terms</a>
    
  </p>
  

  <p class="powered-by">
    &copy; 2019 Eric S. Kawaguchi &middot; 

    Powered by the
    <a href="https://sourcethemes.com/academic/" target="_blank" rel="noopener">Academic theme</a> for
    <a href="https://gohugo.io" target="_blank" rel="noopener">Hugo</a>.

    
    <span class="float-right" aria-hidden="true">
      <a href="#" class="back-to-top">
        <span class="button_icon">
          <i class="fas fa-chevron-up fa-2x"></i>
        </span>
      </a>
    </span>
    
  </p>
</footer>

  </div>
  

  
<div id="modal" class="modal fade" role="dialog">
  <div class="modal-dialog">
    <div class="modal-content">
      <div class="modal-header">
        <h5 class="modal-title">Cite</h5>
        <button type="button" class="close" data-dismiss="modal" aria-label="Close">
          <span aria-hidden="true">&times;</span>
        </button>
      </div>
      <div class="modal-body">
        <pre><code class="tex hljs"></code></pre>
      </div>
      <div class="modal-footer">
        <a class="btn btn-outline-primary my-1 js-copy-cite" href="#" target="_blank">
          <i class="fas fa-copy"></i> Copy
        </a>
        <a class="btn btn-outline-primary my-1 js-download-cite" href="#" target="_blank">
          <i class="fas fa-download"></i> Download
        </a>
        <div id="modal-error"></div>
      </div>
    </div>
  </div>
</div>

</body>
</html>
